By Priyanka Kiritharan, Analyst Email: [email protected] Last month, France’s HTA body; Haute Autorite De Sante (HAS) changed its criteria that triggers the cost-effectiveness evaluation of products
By Erfan Akbraian, Analyst Email: [email protected] In recent years there have been discussions to shift to a multi-stakeholder approach and increase early communication amongst key
Leading specialist market access consultancy Partners4Access (P4A) is to host a free webinar to share insights on key 2021 trends in market access for pharma/biotech
2019 set the tone for innovative therapies in the cell and gene therapy space along with huge interest from Big Biotech. With an expected double
